Fitterfly personalises diabetes management with digital therapeutics

Nopember 29, 2021 Bullet Artikel
Arbinder SingalArbinder Singal
MERAH 2021 Transformasi Perawatan Kesehatan India
Bagikan:
Salin tautan
Fitterfly personalises diabetes management with digital therapeutics (RED 2021)

Fitterfly is an India-based company that provides solutions for chronic disease management. In this session, Fitterfly CEO and Co-Founder Dr Arbinder Singal discusses Diabefly, a digital therapeutics system that collects and analyses personal health data in order to deliver medical and lifestyle interventions.

Watch the full talk below.

Bagikan:
Salin tautan

Lainnya dalam topik yang sama

Select a related post from the options below.

Gemii leverages WeChat to improve Chinese healthcare

Asia’s rapidly changing health insurance landscape (RED 2021)

Rekomendasi topik

SekuensingMERAH 2020Penyakit langka
Bacaan Berikutnya
Manajemen
• Artikel
Creating a healthier Singapore with digital solutions: Q&A with Glenn Neo
How Awanui Group drives diagnostic excellence in New Zealand: Q&A with Anoop Singh (Part 1)
Manajemen
• Artikel
Awanui Group’s quest to improve lab diagnostics in New Zealand: Q&A with Anoop Singh (Part 1)
‘Real world evidence’ and clinical labs: a brief introduction
Operasi
• Artikel
‘Real world evidence’ and clinical labs: a brief introduction
‘Chasing the Invisible’ and the future of the clinical lab: Q&A with Dr Thomas Grogan (Part 3)
Operasi
• Artikel
‘Chasing the Invisible’ and the future of the clinical lab: Q&A with Dr Thomas Grogan (Part 3)
Scroll to Top